All children should have risk assessment for hearing changes; prompt objective screening recommended in case of clinical or caregiver concern.
News and Features
Though in key measures of understandability and actionability, materials performed worse than institution-generated materials.
Self-reported and clinical outcomes similar to those seen with audiologist-fitted hearing aids.
Risk for all-cause dementia increased for those with hearing loss without hearing aids, but not for those with hearing aid use.
The approval was based on data from the phase 3 BUTTERFLEYE and FIREFLEYE trials.
Socially disadvantaged children less likely to receive treatment for recurrent or suppurative otitis media
Pedmark is the first FDA-approved therapy indicated to reduce the risk of cisplatin-induced hearing loss in children.
The approval was based on data from 2 pivotal phase 3 trials, which evaluated Pedmark in pediatric patients undergoing treatment with cisplatin-based chemotherapy.
The final rule takes effect in 60 days and consumers will be able to purchase hearing aids directly from stores or online retailers as soon as mid-October.
No increased risk for tinnitus seen with low-dose aspirin, but increase seen with moderate-dose aspirin for those younger than 60 years, NSAIDS, acetaminophen
The application could not be approved in its present form due to manufacturing deficiencies.
Proposal would create a category of hearing aids that could be sold directly to consumers, without medical exam or audiologist fitting
Study findings did show high adherence to guidelines with respect to medication use.
Cumulative incidence highest in patients aged 5 years and younger; factors that influence development include cumulative dose of cisplatin
Magnitude of elevated risk similar among women who did and did not use bisphosphonates
Rate of episodes of acute otitis media not significantly lower with tympanostomy-tube placement versus medical management
Current evidence insufficient for assessing balance of benefits and harms of screening for asymptomatic older adults
OtoSet is an automated ear cleaning device that resembles a set of headphones.
The otic suspension is a combination of ciprofloxacin, a fluoroquinolone antibacterial and dexamethasone, a corticosteroid.